Xtx Topco LTD Agios Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 9,272 shares of AGIO stock, worth $277,881. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,272
Previous 8,329
11.32%
Holding current value
$277,881
Previous $370,000
17.84%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding AGIO
# of Institutions
239Shares Held
60MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$170 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$169 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$146 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$105 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$72.6 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.64B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...